Due to the assumed regulatory role of kisspeptin on the HPO axis, the use of kisspeptin antagonist may be an appropriate therapeutic method for hormonal disorders, especially GnRH/LH pulse frequency in PCOS subjects (12, 13). The gene discussed is GNRH1; the disease is polycystic ovary syndrome.